SCHEMBL5809160

SCHEMBL5809160

O=C(NN=Cc1ccc(F)cc1O)c1ccncc1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.78
KMT2A Q03164 7/20 0.78
NPC1 O15118 6/20 0.78
RAB9A P51151 4/20 0.78
L3MBTL1 Q9Y468 7/20 0.69
HTT P42858 2/20 0.69
KDM4E B2RXH2 8/20 0.63
MAPT P10636 3/20 0.63
TDP1 Q9NUW8 3/20 0.63
MITF O75030 2/20 0.63
ASF1A Q9Y294 1/20 0.63
GPR174 Q9BXC1 1/20 0.63
GAA P10253 1/20 0.61
USP2 O75604 1/20 0.58
MCOLN3 Q8TDD5 1/20 0.58
LMNA P02545 1/20 0.58
PKM P14618 1/20 0.58
SMN1; SMN2 Q16637 1/20 0.58
SAE1 Q9UBE0 1/20 0.58
UBA2 Q9UBT2 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5810164 1.00 MEN1 (0.78) MEN1KMT2ANPC1RAB9AL3MBTL1
SCHEMBL5809159 1.00 MEN1 (0.78) MEN1KMT2ANPC1RAB9AL3MBTL1
SCHEMBL12443166 0.88 MEN1 (1.00) MEN1KMT2ANPC1RAB9AL3MBTL1
SCHEMBL29382751 0.82 KDM4E (0.72) MEN1KMT2ANPC1RAB9AL3MBTL1
SCHEMBL5815393 0.82 KDM4E (0.72) MEN1KMT2ANPC1RAB9AL3MBTL1
SCHEMBL5809052 0.82 KDM4E (0.72) MEN1KMT2ANPC1RAB9AL3MBTL1
SCHEMBL723372 0.82 KDM4E (0.72) MEN1KMT2ANPC1RAB9AL3MBTL1
Salinazid SCHEMBL1173696 0.82 NPC1 (1.00) MEN1KMT2ANPC1RAB9AL3MBTL1
Salinazid SCHEMBL29444172 0.82 NPC1 (1.00) MEN1KMT2ANPC1RAB9AL3MBTL1
Salinazid SCHEMBL564002 0.82 NPC1 (1.00) MEN1KMT2ANPC1RAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2006136008-A1 SALICYLIC ACID HYDRAZONES AS INHIBITORS OF THE ERK MAPKINASE PATHWAY AND FOR THE TREATMENT OF CANCER UNIVERSITY HEALTH NETWORK (CA) 2006-12-28 WO claimed
WO-2006136008-A1 SALICYLIC ACID HYDRAZONES AS INHIBITORS OF THE ERK MAPKINASE PATHWAY AND FOR THE TREATMENT OF CANCER UNIVERSITY HEALTH NETWORK (CA) 2006-12-28 WO disclosed